HES1 and squamous cell carcinoma: Except for the endometrium, HES1 was also estimated as a transcription factor in squamous cell carcinoma tissue, kidney IRI and Sham disease model, and lymph tissue, which has been reported as one of the downstream effectors of the Notch signaling pathway (87).